Halozyme Therapeutics Inc (HALO) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $32,196,746.91
Most recent insider trade:
  • Sept. 22, 2025
Most active insider trader:
  • Michael J Labarre
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 16, 2023CFO2,525$49.26Sell$124,381.50
Feb. 15, 2023SVP10,000$48.39Sell$483,900.00
Feb. 8, 2023CEO10,000$51.36Sell$513,600.00
Jan. 19, 2023CEO10,000$52.41Sell$524,100.00
Jan. 17, 2023SVP10,000$50.46Sell$504,600.00
Dec. 15, 2022CEO10,000$57.37Sell$573,700.00
Dec. 13, 2022SVP10,000$58.67Sell$586,700.00
Dec. 5, 2022Director10,000$55.74Sell$557,400.00
Dec. 2, 2022Director10,000$58.80Sell$588,000.00
Nov. 17, 2022CEO10,000$52.15Sell$521,500.00
Nov. 15, 2022SVP10,000$54.13Sell$541,300.00
Nov. 15, 2022CFO5,000$53.81Sell$269,050.00
First«2 of 2»Last
  • Insiders are selling Halozyme Therapeutics Inc stock.

  • The insider traders at Halozyme Therapeutics Inc are: Michael J Labarre, Helen Torley, Jeffrey William Henderson, Nicole Labrosse, Matthew L Posard, James M Daly, and Bernadette Connaughton

  • The most active insider trader at Halozyme Therapeutics Inc is Michael J Labarre with 22 trades.

  • Helen Torley has sold the most Halozyme Therapeutics Inc stock with a total value of $15,052,964.86.

  • The most recent insider trade for Halozyme Therapeutics Inc was on Sept. 22, 2025.

  • The single biggest insider sell for Halozyme Therapeutics Inc was from Nicole Labrosse with a total value of $1,514,200.00 on Sept. 10, 2025.